Erol Fikrig MD
Professor, Internal Medicine, Yale University School of Medicine
Join to View Full Profile
789 Howard AveDana Building - 3rd FloorNew Haven, CT 06519
Phone+1 203-785-4629
Fax+1 203-785-3588
Are you Dr. Fikrig?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Erol Fikrig, MD is a rheumatologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and Tennessee. He is a Professor at Yale University School of Medicine.
Education & Training
Yale-New Haven Medical CenterFellowship, Infectious Disease, 1988 - 1991
Vanderbilt University Medical CenterResidency, Internal Medicine, 1985 - 1988
Weill Cornell MedicineClass of 1985
Certifications & Licensure
CT State Medical License 1988 - 2025
TN State Medical License 1987 - 1988
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Secretory leukocyte protease inhibitor influences periarticular joint inflammation in B. burgdorferi-infected mice.Qian Yu, Xiaotian Tang, Thomas Hart, Robert Homer, Alexia A Belperron
Biorxiv. 2025-03-28 - Two Mosquito Salivary Antigens Demonstrate Promise as Biomarkers of Recent Exposure to Plasmodium falciparum-Infected Mosquito Bites.Sarah Lapidus, Morgan M Goheen, Mouhamad Sy, Awa B Deme, Ibrahima Mbaye Ndiaye
The Journal of Infectious Diseases. 2025-03-17 - mosGILT antibodies interfere with Plasmodium sporogony in Anopheles gambiae.Brady Dolan, Tomás Correa Gaviria, Yuemei Dong, Peter Cresswell, George Dimopoulos
Nature Communications. 2025-01-11
Press Mentions
Yale Researchers Advance Work in Diagnosing and Preventing Tick-Borne DiseasesMarch 26th, 2025- National Academy of Medicine Elects Two from Yale School of MedicineOctober 21st, 2024
- Protein in Mosquito Saliva Helps Viruses Spread to HumansAugust 19th, 2024
- Join now to see all
Grant Support
- Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne PathogensUNIV OF MARYLAND, COLLEGE PARK2018–2030
- A novel Lyme disease vaccineYALE UNIVERSITY2022–2027
- The mosquito salivary protein AgBR1 as vaccine candidate against ChikungunyaL2 DIAGNOSTICS, LLC2024–2026
- A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitorL2 DIAGNOSTICS, LLC2024–2026
- A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogensL2 DIAGNOSTICS, LLC2024–2026
- A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitorL2 DIAGNOSTICS, LLC2024–2026
- The mosquito salivary protein AgBR1 as vaccine candidate against ChikungunyaL2 DIAGNOSTICS, LLC2024–2026
- The mosquito salivary protein AgBR1 as vaccine candidate against ChikungunyaL2 DIAGNOSTICS, LLC2024–2026
- The mosquito salivary protein AgBR1 as vaccine candidate against ChikungunyaL2 DIAGNOSTICS, LLC2024–2026
- The mosquito salivary protein AgBR1 as vaccine candidate against ChikungunyaL2 DIAGNOSTICS, LLC2024–2026
- The mosquito salivary protein AgBR1 as vaccine candidate against ChikungunyaL2 DIAGNOSTICS, LLC2024–2026
- A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitorL2 DIAGNOSTICS, LLC2024–2026
- A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitorL2 DIAGNOSTICS, LLC2024–2026
- A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitorL2 DIAGNOSTICS, LLC2024–2026
- A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitorL2 DIAGNOSTICS, LLC2024–2026
- A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitorL2 DIAGNOSTICS, LLC2024–2026
- Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of miceYALE UNIVERSITY2021–2026
- A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1L2 DIAGNOSTICS, LLC2019–2025
- A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1L2 DIAGNOSTICS, LLC2019–2025
- A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1L2 DIAGNOSTICS, LLC2019–2025
- A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1L2 DIAGNOSTICS, LLC2019–2025
- A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1L2 DIAGNOSTICS, LLC2019–2025
- Circadian Rhythms and Innate Immune Response in AgingYALE UNIVERSITY2019–2025
- A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1L2 DIAGNOSTICS, LLC2019–2025
